Delivery without the barriers

Traditional tablets rely on heat and compression, and swallowed doses face stomach acid and digestive enzymes. For peptides and heat-sensitive molecules that is a problem. Pete Pharma's intramucosal strips are built differently: no heat, no compression, no gut.

Peptides like BPC-157, sermorelin, oxytocin, TB-500, GHK-Cu and PT-141 are large, fragile molecules. Heat unravels them; digestive enzymes dismantle them. The intramucosal strip sidesteps both: our PuraFilm-3D plant-based polymer film hydrates, casts and dries entirely at ambient temperature, then releases across the richly vascular tissue of the mouth in about 60 seconds.

The strip is also the backbone of the Pete Pharma GLP-1 compounding platform. Semaglutide, tirzepatide and retatrutide are prepared with a room-temperature, digitally controlled process; one validated base scales cleanly across the dose steps a GLP-1 titration requires, in a taste-masked format patients will keep taking. Semaglutide, tirzepatide and retatrutide are used only where clinically appropriate and legally permissible; suitability, route, dose and sourcing are determined by the licensed prescriber and pharmacist.

Built for: semaglutide, tirzepatide, retatrutide, BPC-157, sermorelin, oxytocin, TB-500, GHK-Cu, PT-141, tadalafil

Who it helps: Peptide therapies, GLP-1 protocols, patients who cannot swallow or inject